ROSLI, Nur Farhanah, Michaela FOJTŮ, Adrian C. FISHER and Martin PUMERA. Graphene Oxide Nanoplatelets Potentiate Anticancer Effect of Cisplatin in Human Lung Cancer Cells. Langmuir. WASHINGTON: AMER CHEMICAL SOC, 1155 16TH ST, NW, WASHINGTON, DC 20036 USA, 2019, vol. 35, No 8, p. 3176-3182. ISSN 0743-7463. Available from: https://dx.doi.org/10.1021/acs.langmuir.8b03086.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Graphene Oxide Nanoplatelets Potentiate Anticancer Effect of Cisplatin in Human Lung Cancer Cells
Authors ROSLI, Nur Farhanah (702 Singapore), Michaela FOJTŮ (203 Czech Republic, belonging to the institution), Adrian C. FISHER (826 United Kingdom of Great Britain and Northern Ireland) and Martin PUMERA (203 Czech Republic, guarantor).
Edition Langmuir, WASHINGTON, AMER CHEMICAL SOC, 1155 16TH ST, NW, WASHINGTON, DC 20036 USA, 2019, 0743-7463.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.557
RIV identification code RIV/00216224:14110/19:00108123
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1021/acs.langmuir.8b03086
UT WoS 000469409800032
Keywords in English TARGETED DELIVERY; CYTOTOXICITY; TOXICITY; NANOCARRIER; LABELS
Tags 14110515, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 28/1/2020 10:26.
Abstract
Graphene oxide (GO) has been widely explored by many in drug delivery strategies and toxicity assays. The toxicity of graphene oxide depends on the size of the sheets. Smaller sheets show lower toxicity, a quality which is essential for utilization in biomedical applications. However, despite vast research on GO, anticancer properties and drug carrier capabilities of graphene oxide nanoplatelets have yet to be fully explored. Herein, we have uniquely prepared graphene oxide nanoplatelets (GONPs) from well-defined stacked graphite nanofibers (SGNF) with a base of 50 x 50 nm(2) for toxicity and drug potentiation studies when coadministered with the chemotherapeutic drug cisplatin (CP) in human lung cancer cells, A549 cells. Results obtained from our studies have found that not only were GONPs able to act as drug carriers, but they can also significantly potentiate anticancer effect of CP in A549 cells.
Links
GA18-24089S, research and development projectName: Kvantitativní fázová mikroskopie pro 3D kvalitativní charakterizaci nádorových buněk
Investor: Czech Science Foundation
PrintDisplayed: 19/7/2024 22:25